A CD30-positive variant of intravascular large B-cell lymphoma presenting as diffuse interstitial lung disease and generalized lymphadenopathy: a case report

Read full text
Authors: Lei Wang, Yongdeng Cai, Mengyao Wang, Cui Gao, Jianni Zhu, Guangwei Xue, Zheng Dong, Changsheng Ge, Wei Zhang, Zongfang Li, Zongtao Liu, Yunqing Chen
+5 more Cailing Du, Changjiang Li, Yajing Liang, Lu Wang, Baomei Mi
Cited by: 0
References: 31

Abstract

Introduction: Intravascular large B-cell lymphoma (IVLBCL) is a rare and aggressive malignancy defined by the proliferation of neoplastic B-cells within the vascular lumen. While the disease can affect multiple organs, commonly manifesting as skin lesions, neurological deficits, or hepatosplenomegaly, it usually spares the lymph nodes and rarely presents as diffuse interstitial lung disease (DILD). We report a 62-year-old man admitted with recurrent fever and progressive dyspnea. Chest computed tomography revealed extensive bilateral interstitial lung disease, with ultrasonography showing generalized lymphadenopathy with preserved architecture. Although initial therapy led to a favorable response, the patient subsequently relapsed. Lymph node biopsy confirmed IVLBCL, characterized by intravascular and intrasinusoidal lymphoma cell infiltration with well-preserved nodal architecture. Notably, the tumor cells showed diffuse strong CD30 expression (~70%), a rare finding potentially linked to the unusual clinical presentation. Conclusion: This case demonstrates that IVLBCL can present with diffuse interstitial lung disease and generalized lymphadenopathy, expanding its recognized phenotypic spectrum. It may represent a variant with CD30-mediated nodal homing and immune activation.

Fields of Study & Subjects

Lymphoma Diagnosis and Treatment CNS Lymphoma Diagnosis and Treatment Viral-associated cancers and disorders

Publication details

Journal / source
Frontiers in Medicine
Volume
13
Pages
1790176–1790176
Publication date
27 February 2026
Language
EN